Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis

Progressive pigmented purpuric dermatosis (PPPD, Schamberg disease) is a rare benign, but chronic dermatosis frequently misdiagnosed as vasculitis or bleeding disorder. Although affected patients experience significant impairment in quality of life no effective treatment has been established. The aim of our two center case series was to evaluate efficacy and tolerability of the antioxidants rutoside and ascorbic acid as combination treatment for PPPD.

[1]  S. Mackay,et al.  Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells , 2013, The Biochemical journal.

[2]  H. Fathy,et al.  Treatment of pigmented purpuric dermatoses with Narrow‐band UVB: a report of six cases , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  R. Glogau,et al.  The successful treatment of Schamberg's disease with the 595 nm vascular laser. , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  C. Huerter,et al.  Purpura annularis telangiectodes of Majocchi: case report and review of the literature , 2009, International journal of dermatology.

[5]  J. Mandl,et al.  Vitamin C: update on physiology and pharmacology , 2009, British journal of pharmacology.

[6]  You Chan Kim,et al.  Treatment of Pigmented Purpuric Dermatosis with Topical Photodynamic Therapy , 2009, Dermatology.

[7]  J. D. de Godoy,et al.  Aminaphtone in the control of Schamberg's disease , 2009, Thrombosis journal.

[8]  S. Rafii,et al.  Platelets, petechiae, and preservation of the vascular wall. , 2008, The New England journal of medicine.

[9]  D. Seckin,et al.  A case of Schamberg's disease responding dramatically to PUVA treatment , 2008, Photodermatology, photoimmunology & photomedicine.

[10]  B. Cribier,et al.  Capillarite purpurique généralisée traitée par PUVAthérapie chez un enfant , 2007 .

[11]  B. Cribier,et al.  [Generalized Schamberg's disease treated with PUVA in a child]. , 2007, Annales de dermatologie et de venereologie.

[12]  F. Laufer.  The treatment of progressive pigmented purpura with ascorbic acid and a bioflavonoid rutoside. , 2006, Journal of drugs in dermatology : JDD.

[13]  T. Luger,et al.  Resolution of lichen aureus in a 10‐year‐old child after topical pimecrolimus , 2004, The British journal of dermatology.

[14]  K. Sardana,et al.  Pigmented purpuric dermatoses: An overview , 2004, International journal of dermatology.

[15]  K. Lahiri,et al.  Oral pentoxifylline vs topical betamethasone in Schamberg disease: a comparative randomized investigator-blinded parallel-group trial. , 2004, Archives of dermatology.

[16]  S. Bhattacharya,et al.  Calcium Dobesilate (Cd) in Pigmented Purpuric Dermatosis (PPD): A Pilot Evaluation , 2004, The Journal of dermatology.

[17]  A. Singal,et al.  Treatment of Schamberg's disease with pentoxifylline--therapeutic trial. , 2003, Indian journal of dermatology, venereology and leprology.

[18]  S. Vanderhooft,et al.  Pigmented Purpuric Eruptions of Childhood: A Series of Cases and Review of Literature , 2001, Pediatric dermatology.

[19]  M. Geller.  Benefit of colchicine in the treatment of Schamberg's disease. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  R. George,et al.  An open trial of pentoxifylline in schamberg's disease. , 2000, Indian journal of dermatology, venereology and leprology.

[21]  S. Ugurel,et al.  Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. , 1999, Journal of the American Academy of Dermatology.

[22]  Y. Miyachi,et al.  Purpura pigmentosa chronica successfully treated with oral cyclosporin A , 1996, The British journal of dermatology.

[23]  S. Nakagawa,et al.  Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer , 1995, Journal of cellular physiology.

[24]  M. Furue,et al.  Successful treatment of pigmented purpuric dermatosis with griseoiulvin , 1995, The British journal of dermatology.

[25]  B. Frei.  Reactive oxygen species and antioxidant vitamins: mechanisms of action. , 1994, The American journal of medicine.

[26]  B. Halliwell,et al.  The role of oxygen radicals in human disease, with particular reference to the vascular system. , 1993, Haemostasis.

[27]  D. Faulds,et al.  Hydroxyethylrutosides , 1992, Drugs.

[28]  B. Peterkofsky.  Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. , 1991, The American journal of clinical nutrition.

[29]  M. Peters,et al.  Purpura simplex (inflammatory purpura without vasculitis): a clinicopathologic study of 174 cases. , 1991, Journal of the American Academy of Dermatology.

[30]  K. V. Ratnam,et al.  A report of two cases of pigmented purpuric dermatoses treated with PUVA therapy. , 1991, Acta dermato-venereologica.

[31]  C. Yuting,et al.  Flavonoids as superoxide scavengers and antioxidants. , 1990 .

[32]  Z. Jia,et al.  Flavonoids as superoxide scavengers and antioxidants. , 1990, Free radical biology & medicine.

[33]  R. Hansen,et al.  Schamberg's Purpura in Children: Case Study and Literature Review , 1987, Clinical pediatrics.

[34]  R. P. Warin,et al.  Textbook of Dermatology , 1987, Bristol Medico-Chirurgical Journal.

[35]  E. F. Sherertz.  Pigmented Purpuric Eruptions , 1984, Seminars in thrombosis and hemostasis.

[36]  B Havsteen,et al.  Flavonoids, a class of natural products of high pharmacological potency. , 1983, Biochemical pharmacology.

[37]  R. Champion,et al.  Pigmented purpuric dermatoses. , 1970, Dermatologica.

[38]  R. Kierland,et al.  Pigmented purpuric eruptions. , 1951, A.M.A. archives of dermatology and syphilology.

[39]  JAY FRANK SCHAMBERG.  REPORT OF THREE CASES OF PROGRESSIVE PIGMENTARY DERMATOSIS, WITH PARTICULAR REFERENCE TO THE BLOOD CHOLESTEROL * , 1927 .